Bullish on Fina Ventures: Ganesh Shanbhag

ET Now spoke to Ganesh Shanbhag of SMS Financial Services on his views on stocks.

ET Now: How do you view Fina Ventures?

Ganesh Shanbhag: Actually it's a small company which was taken over by a company called Aanjaneya Biotech, which is a small pharmaceutical company.

They did an open offer and there will be a reverse merger happening in Fina Venture. That would actually trigger the stock over a period of time because Aanjaneya Biotech is in some biotech space which looks pretty interesting. So the valuation of Fina Ventures as and when the merger goes through will automatically change.

ET Now: Is there some visible financial model for Aanjaneya Biotech?

Ganesh Shanbhag: I think they are doing quite well and that is why instead of going in for an IPO, they are planning on a reverse merger. That's why we see valuations changing in this company over a period of time.